Pfizer and BioNTech have begun submitting a formal request to United States health regulators for emergency use of their COVID-19 vaccine for children aged over six months and under five years:
Pfizer and BioNTech have begun submitting a formal request to United States health regulators for emergency use of their Covid vaccine for children aged over six months and under five years.
In a tweet soon after the announcement, the FDA said it will hold a meeting on 15 February to consider the request. "If two doses are authorized, parents will have the opportunity to begin a Covid-19 vaccination series for their children while awaiting potential authorization of a third dose," he added.
Data on the three-dose regimen is "expected in the coming months and will be submitted to the FDA to support a potential expansion" of this initial request, Pfizer and BioNTech said in a press release.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Australian music legend dies from COVID-19 complicationsGlenn Wheatley, who managed both John Farnham and Delta Goodrem, died in Melbourne on Tuesday from COVID-19 complications.
Read more »
Why WA should look to Tasmania, not NSW, for a glimpse into its COVID-19 futureWhile Mark McGowan constantly reels off the death tallies in states like NSW and Victoria, he often fails to provide an update on how other states are faring. The outcomes are much less grim.
Read more »
Denmark becomes first EU country to scrap most COVID-19 restrictionsDenmark has become the first European Union country to scrap most pandemic restrictions as the Scandinavian country no longer considers the COVID-19 outbreak "a socially critical disease".
Read more »
Scott Morrison admits mistakes and expresses regret over government’s COVID-19 responseThe prime minister used his first major speech of 2022 to admit he hasn't got 'everything right' in a nod to community frustrations towards challenges caused by the Omicron variant.
Read more »